Brett Tucker - G Medical Company Sec
| GMVDDelisted Stock | USD 0.33 0.01 2.94% |
Insider
Brett Tucker is Company Sec of G Medical Innovations
| Phone | 972 8 958 4777 |
| Web | https://gmedinnovations.com |
G Medical Management Efficiency
The company has return on total asset (ROA) of (2.2333) % which means that it has lost $2.2333 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (8.6521) %, meaning that it created substantial loss on money invested by shareholders. G Medical's management efficiency ratios could be used to measure how well G Medical manages its routine affairs as well as how well it operates its assets and liabilities.G Medical Innovations currently holds 2.09 M in liabilities with Debt to Equity (D/E) ratio of 0.44, which is about average as compared to similar companies. G Medical Innovations has a current ratio of 1.01, suggesting that it is not liquid enough and may have problems paying out its financial obligations when due. Note, when we think about G Medical's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| MS MD | Femasys | N/A | |
| Joseph Driscoll | Akoya Biosciences | 59 | |
| Robert Hayes | Sharps Technology | 57 | |
| Robert Myers | Predictive Oncology | 67 | |
| BS BSc | Predictive Oncology | 73 | |
| Robert MBA | Predictive Oncology | 69 | |
| David Stefansky | Nexgel Inc | 53 | |
| Rachel Vaknin | Microbot Medical | 45 | |
| Dov Elefant | Femasys | 57 | |
| Barry Berler | Sharps Technology | 70 | |
| Yury Goltsev | Akoya Biosciences | N/A | |
| Steven Damon | Femasys | 68 | |
| Marilee MBA | Akoya Biosciences | 65 | |
| David BA | GlucoTrack | 59 | |
| Erez BenZvi | GlucoTrack | 46 | |
| Julia Kirshner | Predictive Oncology | N/A | |
| Adam III | Nexgel Inc | 47 | |
| Edward MD | Femasys | 61 | |
| Nikolay Samusik | Akoya Biosciences | N/A | |
| Steven MD | Sharps Technology | 62 | |
| Theresa Ferguson | Predictive Oncology | N/A | |
Management Performance
| Return On Equity | -8.65 | |||
| Return On Asset | -2.23 |
G Medical Innovations Leadership Team
Elected by the shareholders, the G Medical's board of directors comprises two types of representatives: G Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of GMVD. The board's role is to monitor G Medical's management team and ensure that shareholders' interests are well served. G Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, G Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Oded Shahar, Sr Acquisition | ||
| Benny Tal, VP CTO | ||
| Kobi Efraim, Controller | ||
| Brett Tucker, Company Sec | ||
| Yacov Geva, CEO and President | ||
| Igor Bluvstein, Chief Officer | ||
| Dror NurielRoth, Ex Operations |
GMVD Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is G Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -8.65 | |||
| Return On Asset | -2.23 | |||
| Operating Margin | (6.20) % | |||
| Current Valuation | 5.92 M | |||
| Shares Outstanding | 9.82 M | |||
| Shares Owned By Insiders | 15.28 % | |||
| Shares Owned By Institutions | 16.91 % | |||
| Number Of Shares Shorted | 68.79 K | |||
| Price To Book | 6.09 X | |||
| Price To Sales | 0.48 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Consideration for investing in GMVD Stock
If you are still planning to invest in G Medical Innovations check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the G Medical's history and understand the potential risks before investing.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |